Ticker > Company >

Hind Bio Science share price

Hindustan Bio Sciences Ltd.

BSE: 532041 SECTOR: Pharmaceuticals & Drugs  13.24 K   14   1

7.82
+0.01 (0.13%)
BSE: 10 Sep 04:01 PM

Price Summary

Today's High

₹ 7.84

Today's Low

₹ 7.51

52 Week High

₹ 13.47

52 Week Low

₹ 6.7

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8.02 Cr.

Enterprise Value

10.54 Cr.

No. of Shares

1.03 Cr.

P/E

266.89

P/B

8.75

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  0.89

CASH

0.04 Cr.

DEBT

2.56 Cr.

Promoter Holding

12.19 %

EPS (TTM)

₹  0.03

Sales Growth

14.15%

ROE

7.43 %

ROCE

1.74%

Profit Growth

242.37 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year14.15%
3 Year0.67%
5 Year-21.64%

Profit Growth

1 Year242.37%
3 Year27.27%
5 Year-12.13%

ROE%

1 Year7.43%
3 Year-15.78%
5 Year-19.33%

ROCE %

1 Year1.74%
3 Year-5.34%
5 Year-7.46%

Debt/Equity

3.1788

Price to Cash Flow

-5.69

Interest Cover Ratio

15.2702

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 12.19 0.00
Mar 2025 12.19 0.00
Dec 2024 12.19 0.00
Sep 2024 12.19 0.00
Jun 2024 12.19 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has a healthy liquidity position with current ratio of 69.0373.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 6.33695174270999.

 Limitations

  • The company has shown a poor revenue growth of 0.669881031887121% for the Past 3 years.
  • Company has a poor ROE of -15.7781107642763% over the past 3 years.
  • Company has a poor ROCE of -5.33975208114347% over the past 3 years
  • Company has high Debt to Equity ratio of 3.1788.
  • Company has negative cash flow from operations of -1.4089627.
  • The company has a low EBITDA margin of -39.7298920660279% over the past 5 years.
  • The company is trading at a high PE of 266.89.
  • The company is trading at a high EV/EBITDA of 328.4414.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0.41 0 0 0.38 0.32
Total Expenditure 0.34 0.05 0.04 0.28 0.32
Operating Profit 0.07 -0.05 -0.04 0.1 0
Other Income 0.01 0 0 0.01 0.01
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.08 -0.05 -0.04 0.11 0.01
Tax 0 0 0 0 0
Profit After Tax 0.08 -0.05 -0.04 0.11 0.01
Adjusted EPS (Rs) 0.08 -0.05 -0.04 0.11 0.01

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1.94 1.03 0.43 0.92 1.05
Total Expenditure 1.81 1.97 0.94 0.95 0.99
Operating Profit 0.14 -0.94 -0.51 -0.03 0.06
Other Income 0 0 0 0 0
Interest 0.01 0.01 0 0 0
Depreciation 0.01 0.01 0 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.12 -0.96 -0.51 -0.04 0.05
Tax 0.04 -0.02 0 0 0
Net Profit 0.08 -0.94 -0.52 -0.04 0.06
Adjusted EPS (Rs.) 0.08 -0.92 -0.5 -0.04 0.06

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 10.25 10.25 10.25 2.05 2.05
Total Reserves -8.01 -8.95 -9.46 -1.3 -1.25
Borrowings 1.67 0.73 1.07 1.12 2.56
Other N/C liabilities -0.01 -0.01 -0.01 0 -0.01
Current liabilities 1.65 1.45 1.12 1.42 0.01
Total Liabilities 5.55 3.48 2.97 3.28 3.37
Assets
Net Block 0.05 0.04 0.04 0.03 0.03
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 3.19 2.39 2.39 2.39 2.39
Other N/C Assets 0 0 0 0 0
Current Assets 2.31 1.05 0.54 0.86 0.95
Total Assets 5.55 3.48 2.97 3.28 3.37
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.12 -0.96 -0.51 -0.04 0.05
Adjustment 0.01 0.04 0.23 0.01 0.01
Changes in Assets & Liabilities 0.71 1.65 -0.06 -0.02 -1.47
Tax Paid -0.02 0.02 0 0 0
Operating Cash Flow 0.82 0.75 -0.34 -0.05 -1.41
Investing Cash Flow 0 0 0 0 0
Financing Cash Flow -0.81 -0.93 0.34 0.05 1.43
Net Cash Flow 0.01 -0.18 -0.01 0 0.03

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 12.19 12.19 12.19 12.19 12.19
j uma 0.01 0.01 0.01 0.01 0.01
j varun varma 0.02 0.02 0.02 0.02 0.02
super solutions india pri... 2.78 2.78 2.78 2.78 2.78
venkata rama mohan raju j... 9.39 9.39 9.39 9.39 9.39
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 87.81 87.81 87.81 87.81 87.81
bosco armando menezes - - - - 1.08
chintalapati deepika 1.37 1.37 1.37 1.37 1.37
danlaw systems india l... 1.30 1.30 1.30 1.30 1.30
emily bosco menezes - - 1.24 1.27 1.54
madhusudan rao polineni - 1.33 1.61 1.61 1.61
satyasai kolli 2.59 2.59 2.59 2.59 2.59
vandana yogesh bhosale 1.65 1.65 1.65 1.65 1.65

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Hind Bio Science - Quaterly Results 31 Jul, 5:01 PM Hind Bio Science - Quaterly Results 31 Jul, 5:01 PM Hind Bio Science - Quaterly Results 31 Jul, 5:01 PM Hindustan Bio Sciences informs about secretarial compliance report 24 May, 4:09 PM Hindustan Bio Sciences informs about integrated filing 4 Mar, 5:31 PM Hind Bio Science - Quaterly Results 30 Jan, 3:01 PM Hind Bio Science - Quaterly Results 30 Jan, 3:01 PM Hind Bio Science - Quaterly Results 30 Jan, 3:01 PM Hind Bio Science - Quaterly Results 30 Oct, 5:08 PM Hind Bio Science - Quaterly Results 30 Oct, 5:08 PM Hind Bio Science - Quaterly Results 30 Oct, 5:08 PM Hind Bio Science - Quaterly Results 31 Jul, 2:48 PM Hind Bio Science - Quaterly Results 31 Jul, 2:48 PM Hind Bio Science - Quaterly Results 31 Jul, 2:48 PM Hind Bio Science - Quaterly Results 25 May, 12:00 PM Hind Bio Science - Quaterly Results 31 Jan, 2:30 PM Hind Bio Science - Quaterly Results 31 Jan, 2:30 PM Hind Bio Science - Quaterly Results 31 Oct, 3:20 PM Hind Bio Science - Quaterly Results 31 Oct, 3:20 PM Hind Bio Science - Quaterly Results 31 Jul, 3:03 PM Hind Bio Science - Quaterly Results 31 Jul, 3:03 PM Hind Bio Science - Quaterly Results 31 Jul, 3:03 PM Hindustan Bio Sciences informs about outcome of board meeting 10 Mar, 3:07 PM Hind Bio Science - Quaterly Results 31 Jan, 3:52 PM Hind Bio Science - Quaterly Results 31 Jan, 3:52 PM Hind Bio Science - Quaterly Results 31 Jan, 3:52 PM Hindustan Bio Sciences informs about on related party transaction 28 Dec, 5:17 PM Hind Bio Science - Quaterly Results 31 Oct, 3:49 PM Hind Bio Science - Quaterly Results 31 Oct, 3:49 PM Hind Bio Science - Quaterly Results 31 Oct, 3:49 PM Hind Bio Science - Quaterly Results 29 Jul, 4:06 PM Hind Bio Science - Quaterly Results 29 Jul, 4:06 PM Hind Bio Science - Quaterly Results 29 Jul, 4:06 PM Hindustan Biosciences informs about revised compliance certificate 4 Jun, 3:17 PM Hindustan Bio Sciences informs about compliance certificate 18 Apr, 5:19 PM Hind Bio Science - Quaterly Results 4 Feb, 3:12 PM Hind Bio Science - Quaterly Results 4 Feb, 3:12 PM Hind Bio Science - Quaterly Results 4 Feb, 3:12 PM Hindustan Biosciences informs about board meeting 24 Jan, 4:56 PM Hindustan Bio Sciences informs about certificate 20 Jan, 4:22 PM Hindustan Bio sciences informs about certificate 23 Oct, 11:42 AM Hindustan Bio Sciences informs about voting results 23 Jul, 1:01 PM Hindustan Bio Sciences informs about newspaper publication 7 May, 2:28 PM Hindustan Bio Sciences informs about certificate 16 Oct, 3:13 PM Hindustan Bio Sciences informs about outcome of board meeting 3 Sep, 2:47 PM

Hind Bio Science Stock Price Analysis and Quick Research Report. Is Hind Bio Science an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hind Bio Science. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hind Bio Science has a PE ratio of 266.894197952218 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hind Bio Science has ROA of 1.732% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hind Bio Science has a Current ratio of 69.0373.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hind Bio Science has a ROE of 7.4277%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hind Bio Science has a Debt to Equity ratio of 3.1788 which means that the company has high proportion of debt in its capital.

  • Sales growth: Hind Bio Science has reported revenue growth of 14.1468% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hind Bio Science for the current financial year is 6.0721700296514%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hind Bio Science is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hind Bio Science is Rs 0.0293. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hind Bio Science in Ticker for free. Also, one can get the intrinsic value of Hind Bio Science by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hind Bio Science FAQs

Q1. What is Hind Bio Science share price today?
Ans: The current share price of Hind Bio Science is Rs 7.82.

Q2. What is the market capitalisation of Hind Bio Science?
Ans: Hind Bio Science has a market capitalisation of Rs 8.0161256 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hind Bio Science?
Ans: The PE ratio of Hind Bio Science is 266.894197952218 and the P/B ratio of Hind Bio Science is 8.74916088610428, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hind Bio Science share?
Ans: The 52-week high share price of Hind Bio Science is Rs 13.47, and the 52-week low share price of Hind Bio Science is Rs 6.7.

Q5. Does Hind Bio Science pay dividends?
Ans: Currently, Hind Bio Science does not pay dividends. Dividend yield of Hind Bio Science is around 0%.

Q6. What are the face value and book value of Hind Bio Science shares?
Ans: The face value of Hind Bio Science shares is Rs 2, while the book value per share of Hind Bio Science is around Rs 0.8938. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hind Bio Science?
Ans: Hind Bio Science has a total debt of Rs 2.5563456 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hind Bio Science?
Ans: The ROE of Hind Bio Science is 7.4277% and ROCE of Hind Bio Science is 1.7395%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hind Bio Science a good buy for the long term?
Ans: The Hind Bio Science long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hind Bio Science undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hind Bio Science appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hind Bio Science’s financials?
Ans: You can review Hind Bio Science’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Hind Bio Science
X